Klebsiella pneumoniae co-producing KPC and RmtG, finally targeting Switzerland

Diagn Microbiol Infect Dis. 2018 Feb;90(2):151-152. doi: 10.1016/j.diagmicrobio.2017.10.019. Epub 2017 Nov 6.

Abstract

A carbapenem- and pan-aminoglycoside-resistant Klebsiella pneumoniae strain was isolated from a Brazilian patient hospitalized in a Swiss hospital. The clinical isolate carried genes encoding the KPC-2 carbapenemase and the RmtG 16S rRNA methyltransferase. This is the first report of a carbapenem-resistant K. pneumoniae producing RmtG in Europe.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / genetics
  • Brazil
  • Cross Infection / epidemiology
  • Cross Infection / microbiology*
  • Disease Outbreaks
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Humans
  • Klebsiella Infections / microbiology*
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / enzymology
  • Klebsiella pneumoniae / genetics*
  • Methyltransferases / genetics
  • Microbial Sensitivity Tests
  • Switzerland

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Methyltransferases